Minimally important differences for subjective improvement in postural stability in patients with bilateral vestibulopathy
Minimally important differences for subjective improvement in postural stability in patients with bilateral vestibulopathy
复制标题
双侧前庭病患者姿势稳定性主观改善的最小重要差异
DOI:
10.1016/j.neulet.2021.135706
复制
发表时间:
2021
影响因子:
2.5
通讯作者:
Iwasaki Shinichi
中科院分区:
文献类型:
--
作者:
Fujimoto Chisato;Kawahara Takuya;Kinoshita Makoto;Ichijo Kentaro;Oka Mineko;Kamogashira Teru;Sugasawa Keiko;Yamasoba Tatsuya;Iwasaki Shinichi
ObjectiveTo determine minimally important differences (MIDs) for subjective improvement in postural stability after a therapeutic intervention in patients with bilateral vestibulopathy (BVP).MethodsThirteen BVP patients received noisy galvanic vestibular stimulation (nGVS) for 30 min and their static posture with eyes closed was monitored after the stimuli. The velocity of the center of pressure (COP) movement, the area enclosed by the COP movement, and the root mean square (RMS) of the displacement of the COP were measured for 30 s. Subjective evaluation of postural stability after nGVS was graded as worsened, slightly worsened, unchanged, slightly improved and improved in comparison with postural stability measured without nGVS. Anchor-based methods were used to estimate MIDs for subjective improvement. Velocity, area and RMS for each anchor-response group were averaged (2 sessions, each with 5 measurement periods during 3 h after the stimuli). The mean changes between the slightly improved group and unchanged group were used as estimates for MID for improvement.ResultsA total of 129 anchors were analyzed. Subjective evaluations numbered 83 (64%) for unchanged and 33 (26%) for slightly improved. Anchor-based methods yielded estimates for MIDs of -0.43 cm/s in velocity improvement (p< 0.01), -0.77 cm2for area improvement (p< 0.01) and -0.23 cm for RMS improvement (p< 0.001).ConclusionThe present study provides the estimation of MIDs for improving postural stability in BVP patients and may be useful for interpreting whether the results from clinical trials are meaningful in future studies.